Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Durata, with license to Pfizer drug, lays plans for $86M IPO
Durata, with license to Pfizer drug, lays plans for $86M IPO
Durata, with license to Pfizer drug, lays plans for $86M IPO
Submitted by
admin
on March 23, 2012 - 12:45pm
Source:
Fierce Biotech
News Tags:
Durata
Pfizer
IPOs
dalbavancin
Headline:
Durata, with license to Pfizer drug, lays plans for $86M IPO
Do Not Allow Advertisers to Use My Personal information
